Disseminated growth of murine plasmacytoma: similarities to multiple myeloma
- PMID: 9458102
Disseminated growth of murine plasmacytoma: similarities to multiple myeloma
Abstract
Murine plasma cell tumors share a number of common features with human multiple myeloma, suggesting their possible use as a model for this disease. However, one major difference between the two is the peritoneal localization of murine tumors as opposed to bone marrow residence of malignant plasma cells in early stages of multiple myeloma. We have thus examined the ability of murine plasmacytoma to produce disseminated growth similar to that seen in myeloma or other lymphoid neoplasias. Of four murine cell lines evaluated, all were demonstrated to effect highly metastatic disease involving multiple organs, although variation was observed between lines. A temporal analysis was accordingly performed with the S107 line to assess the pattern of cellular localization. Both light microscopy and PCR analysis revealed that engraftment of plasma cells occurs first in the bone marrow, followed by dissemination to other sites including the spleen, lung, and liver. Cells passaged in vivo through the bone marrow display an entirely different metastatic pattern with no homing preference to bone marrow or any other organ, suggesting the occurrence of a phenotypic change. Microscopic osteolytic lesions were observed adjacent to plasma cell tumor masses in the bone marrow, indicating early stages of bone disease. These findings demonstrate previously unrecognized similarities between the murine and human diseases and suggest the use of this in vivo model for experimental approaches to the treatment of human disease.
Similar articles
-
Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse.Br J Cancer. 2000 Feb;82(4):953-9. doi: 10.1054/bjoc.1999.1024. Br J Cancer. 2000. PMID: 10732771 Free PMC article.
-
ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.Leuk Res. 2005 Apr;29(4):435-44. doi: 10.1016/j.leukres.2004.09.007. Epub 2004 Dec 18. Leuk Res. 2005. PMID: 15725478
-
Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.Bone Marrow Transplant. 1996 Jul;18(1):103-10. Bone Marrow Transplant. 1996. PMID: 8832002
-
Homing mechanisms in the biology of multiple myeloma.Verh K Acad Geneeskd Belg. 1998;60(3):163-94. Verh K Acad Geneeskd Belg. 1998. PMID: 9803879 Review.
-
Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.Verh K Acad Geneeskd Belg. 2003;65(2):127-34. Verh K Acad Geneeskd Belg. 2003. PMID: 12870183 Review.
Cited by
-
Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5181-6. doi: 10.1073/pnas.081275298. Epub 2001 Apr 17. Proc Natl Acad Sci U S A. 2001. PMID: 11309490 Free PMC article.
-
Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.Hum Gene Ther Clin Dev. 2016 Sep;27(3):111-22. doi: 10.1089/humc.2016.061. Hum Gene Ther Clin Dev. 2016. PMID: 27532609 Free PMC article.
-
Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia.Med Oncol. 1999 Jul;16(2):119-28. doi: 10.1007/BF02785845. Med Oncol. 1999. PMID: 10456660
-
Multiple myeloma in a murine syngeneic model:modulation of growth and angiogenesis by a monoclonal antibody to kininogen.Cancer Immunol Immunother. 2006 Jul;55(7):797-807. doi: 10.1007/s00262-005-0068-8. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical